Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis

BACKGROUND AND AIM: The use of biologics and small molecules has been a concern for patients with inflammatory bowel disease (IBD) during the COVID‐19 pandemic. We aimed to assess the association between the risk of COVID‐19‐related hospitalization and these agents. METHODS: We made a systematic rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Alrashed, Fatema, Alasfour, Hajer, Shehab, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021715/
https://www.ncbi.nlm.nih.gov/pubmed/35475207
http://dx.doi.org/10.1002/jgh3.12728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021715/
https://www.ncbi.nlm.nih.gov/pubmed/35475207
http://dx.doi.org/10.1002/jgh3.12728

Ejemplares similares